Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CompuMed Inc. (CMPD : OTC)

• Company Description    COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $4.50 Daily Weekly Monthly 20 Day Moving Average: 902 shares Shares Outstanding: 1.33 (millions) Market Capitalization: $5.97 (millions) Beta: -0.05 52 Week High: $4.75 52 Week Low: $2.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.27% 0.47% 12 Week 49.75% 36.03% Year To Date 18.11% 5.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5777 West Century Blvd. Suite 360 - Los Angeles,CA 90045 USA ph: 310-258-5000 fax: 310-645-5880 investorrelations@compumedinc.com http://www.compumedinc.com

• General Corporate Information    Officers Lee Keddie - Chief Executive Officer and President David W. Pointer - Chairman Laura Carroll - Chief Financial Officer and Corporate Secretary Loren Den Herder - Director Charles Gillman - Director Peer Information CompuMed Inc. (BJCT) CompuMed Inc. (CADMQ) CompuMed Inc. (APNO) CompuMed Inc. (UPDC) CompuMed Inc. (IMTIQ) CompuMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 204914501 SIC: 7374 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 12/15/25 Share - Related Items Shares Outstanding: 1.33 Most Recent Split Date: 5.00 (0.04:1) Beta: -0.05 Market Capitalization: $5.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/15/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 26.47 PEG Ratio: - Price Ratios Price/Book: 1.74 Price/Cash Flow: 6.54 Price / Sales: 0.84 EPS Growth vs. Year Ago Period: -50.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 20.74% vs. Previous Quarter: 6.32% ROE 06/30/25 - 4.82 03/31/25 - 6.43 12/31/24 - 6.85 ROA 06/30/25 - 3.32 03/31/25 - 4.53 12/31/24 - 4.96 Current Ratio 06/30/25 - 2.28 03/31/25 - 2.72 12/31/24 - 3.15 Quick Ratio 06/30/25 - 2.26 03/31/25 - 2.55 12/31/24 - 2.85 Operating Margin 06/30/25 - 2.26 03/31/25 - 3.13 12/31/24 - 3.44 Net Margin 06/30/25 - 2.26 03/31/25 - 3.13 12/31/24 - 3.44 Pre-Tax Margin 06/30/25 - 0.17 03/31/25 - 0.93 12/31/24 - 0.86 Book Value 06/30/25 - 2.58 03/31/25 - 2.55 12/31/24 - 2.51 Inventory Turnover 06/30/25 - 7.03 03/31/25 - 4.02 12/31/24 - 2.76 Debt-to-Equity 06/30/25 - 0.16 03/31/25 - 0.18 12/31/24 - 0.09 Debt-to-Capital 06/30/25 - 13.75 03/31/25 - 15.15 12/31/24 - 8.12

Powered by Zacks Investment Research ©